Phase II study of docetaxel, cisplatin and modulated oral tegafur (DCT) in advanced gastric cancer (AGC)

被引：0
|
作者：
Pericay, Carles
Losa, Ferran
Nogue, Miquel
Gallardo, Enrique
Fernandez-Morales, Luis
Dalmau, Elsa
Martinez-Peralta, Susana
Santos-Vivas, Cristina
Pous, Enric
Saigi, Eugeni
机构：
[1] Hosp Sabadell, Sabadell, Spain
[2] Hosp Gen lHospitalet, Lhospitalet De Llobregat, Spain
[3] Hosp Gen Vic, Vic, Spain
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：324 / 324
页数：1
相关论文
共 50 条
  • [1] Phase II of epirubicin, cisplatin and modulated oral tegafur (EPT) in advanced gastric cancer (AGC)
    Gallardo, Enrique
    Batiste-Alentorn, Eduard
    Escudero, Pilar
    Alfaro, Jordi
    Pericay, Carles
    Losa, Ferran
    Esquerdo, Gaspar
    Alonso, Vicente
    Gallen, Manuel
    Arroyo, Monica
    ANNALS OF ONCOLOGY, 2004, 15 : 239 - 239
  • [2] Epirubicin, cisplatin and oral tegafur with levofolinate (ECT) in patients with advanced gastric cancer (AGC):: A pilot study.
    Gallardo, E
    Arcusa, A
    Saigí, E
    Nogué, M
    Blanco, R
    Seguí, MA
    Gallén, M
    ANNALS OF ONCOLOGY, 2000, 11 : 65 - 65
  • [3] Phase II study of docetaxel combined with cisplatin in advanced gastric cancer.
    Park, YS
    Park, KW
    Lee, J
    Kang, JH
    Kim, HY
    Park, JO
    Lee, SH
    Kang, WK
    Park, K
    Lee, SI
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 327S - 327S
  • [4] A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer
    C-P Li
    J-S Chen
    L-T Chen
    C-J Yen
    K-D Lee
    W-P Su
    P-C Lin
    C-H Lu
    H-J Tsai
    Y Chao
    British Journal of Cancer, 2010, 103 : 1343 - 1348
  • [5] Phase II study of docetaxel, cisplatin, and irinotecan in advanced esophageal and gastric cancer.
    Enzinger, PC
    Clark, J
    Ryan, D
    Meyerhardt, J
    Kulke, M
    Fidias, P
    Earle, C
    Vincitore, M
    Michelini, A
    Fuchs, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 323S - 323S
  • [6] A Multicentre phase II study of docetaxel plus cisplatin for the treatment of advanced gastric cancer
    Fahlke, J.
    Ridwelski, K.
    Schmidt, C.
    Hribaschek, K.
    Stuebs, P.
    Kettner, E.
    Quietzsch, D.
    Assmann, M.
    Deist, T.
    Keilholz, U.
    Lippert, H.
    CHEMOTHERAPY, 2007, 53 (06) : 454 - 460
  • [7] A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer
    Li, C-P
    Chen, J-S
    Chen, L-T
    Yen, C-J
    Lee, K-D
    Su, W-P
    Lin, P-C
    Lu, C-H
    Tsai, H-J
    Chao, Y.
    BRITISH JOURNAL OF CANCER, 2010, 103 (09) : 1343 - 1348
  • [8] A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma
    Woo, IS
    Moon, DH
    Shim, BY
    Lee, MA
    Byun, JH
    Kim, KW
    Kang, JH
    Choi, MG
    Chung, IS
    Hong, YS
    Park, SY
    Lee, KS
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (01) : 13 - 17
  • [9] Docetaxel and cisplatin in patients with advanced gastric cancer: results of Japanese phase I/II study
    Soh Saitoh
    Yuh Sakata
    Gastric Cancer, 2002, 5 (Suppl 1) : 23 - 26
  • [10] Docetaxel and cisplatin in patients with advanced or recurrent gastric cancer: A multicenter phase I/II study
    Mitachi Y.
    Sakata Y.
    Ohtsu A.
    Hyodo I.
    Katsu K.
    Sairenji M.
    Saitoh S.
    Suwa T.
    Sato T.
    Miyata Y.
    Gastric Cancer, 2002, 5 (3) : 160 - 167
12345